OpenAI has announced the launch of ChatGPT Pro, which enables users to access the best of OpenAI’s models and tools.
Priced at $200 per month, this plan includes unlimited access to its smartest model, OpenAI o1, as well as to o1-mini, GPT-4o, and Advanced Voice.
It also includes o1 pro mode, a version of o1 that uses more computing to think harder and provide even better answers to the hardest problems.
In the near future, OpenAI plans to add features like web browsing, file uploads, and image processing in the future. Right now, the o1 model allows users to upload and work with images for different tasks.
ChatGPT Pro: More thinking power for complex problems
Unlike the standard plans, ChatGPT Pro provides access to a version of OpenAI’s most intelligent model that thinks longer for the most reliable responses.
In evaluations from external expert testers, o1 pro mode produces more reliably accurate and comprehensive responses, especially in areas like data science, programming, and case law analysis.
Compared to o1 and o1-preview, o1 pro mode performs better on challenging ML benchmarks across math, science, and coding.
OpenAI’s o1 Pro mode has shown major improvements in benchmark tests. In AIME 2024, it scored 86 points, while o1-preview scored only 50. On Codeforces, o1 Pro got 90 points, compared to 62 points for o1-preview.
ChatGPT Pro users can access this functionality by selecting o1 pro mode in the model picker and asking a question directly.
Since answers will take longer to generate, ChatGPT will display a progress bar and send an in-app notification if you switch away to another conversation.
Besides the launch announcement, OpenAI is also awarding 10 ChatGPT Pro grants to medical researchers at top U.S. institutions to support progress in fields that benefit humanity.
The initial recipients are:
- Catherine Brownstein, MPH, PhD: Assistant Professor at Boston Children’s Hospital and Harvard Medical School, focusing on rare diseases.
- Justin Reese, PhD: Computer Research Scientist at Berkeley Lab, using biomedical data to address human diseases.
- Rhoda Au, PhD: Professor at Boston University, researching ageing and dementia.
- Derya Unutmaz, MD: Professor at The Jackson Laboratory, studying ageing and cancer immunotherapy.
01
From port to startup fort: How Lars Crama is ‘Making it Happen’ in Rotterdam